Expression of Vascular Endothelial Growth Factor in Canine Inflammatory and Non-inflammatory Mammary Carcinoma

Journal of Comparative Pathology

Volumn 142, Issue 1, 2010, Pages 36-42

  Millanta, F ^a   Caneschi, V ^a   Ressel, L ^a   Citi, S ^a   Poli, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

dog; HER 2; inflammatory mammary carcinoma; mammary tumours; steroid receptor; VEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DOG DISEASE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY MAMMARY CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CANIS FAMILIARIS;

EID: 71149118762     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.06.004     Document Type: Article

References (35)

1. Chambler A.F., Drew P.J., Hill A.D., Darzi A., and Monson J.R. Inflammatory breast carcinoma. Surgical Oncology 4 (1995) 245-254
2. Chevallier B., Asselain B., Kunlin A., Veyret C., Bastit P., et al. Inflammatory breast cancer: determination of prognostic factors by univariate and multivariate analysis. Cancer 60 (1987) 897-902
3. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade breast cancer: experience from a large study with a long-term follow-up. Histopathology 19 (1991) 403-410
4. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. Journal of Molecular Medicine 77 (1999) 527-543
5. Folkman J., and Shing Y. Angiogenesis. Journal of Biological Chemistry 267 (1992) 10931-10934
6. Fox S.B., Gasparini G., and Harris A.L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their links to trial design and anticancer drugs. Lancet Oncology 2 (2001) 278-289
7. Kleer C.G., van Golen K.L., and Merajver S.D. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Research 2 (2000) 423-429
8. Kleer C.G., Zhang Y., Pan Q., Gallagher G., Wu M., et al. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Research 6 (2004) R110-R115
9. Koeppen H.K.W., Wright B.D., Burt A.D., Quirke P., McNicol A.M., et al. Over-expression of HER2/neu in solid tumours: an immunohistochemical survey. Histopathology 38 (2001) 96-104
10. Lewis J.S., Landers R.J., Underwood J.C.E., and Harris A.L. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. Journal of Pathology 192 (2000) 150-158
11. Liauw S.L., Benda R.K., Morris C.G., and Mendenhall N.P. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer 100 (2004) 920-928
12. McCarthy N.J., Xiaowei Y., Linnoila I.R., Merino M.J., Hewitt S.M., et al. Microvessel density, expression of estrogen receptor-α, MIB-1, p53 and c-erbB-2 in inflammatory breast cancer. Clinical Cancer Research 8 (2002) 3857-3862
13. Martìn de las Mulas J., Ordàs J., Millàn Y., Fernandez-Soria V., and Ramòn y Cajal S. Oncogene HER-2 in canine mammary gland carcinomas. An immunohistochemical and chromogenic in situ hybridization study. Breast Cancer Research and Treatment 80 (2003) 363-367
14. Martìn de las Mulas J., Millàn Y., and Dios R. A prospective analysis of immunohistochemical determined estrogen receptor α and progesterone receptor expression and host and tumour factors as predictors of disease-free period in mammary tumours of the dog. Veterinary Pathology 42 (2005) 200-212
15. Millanta F., Lazzeri G., Vannozzi I., Viacava P., and Poli A. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Veterinary Pathology 39 (2002) 690-696
16. Millanta F., Bari G., Niccolini M., Vannozzi I., and Poli A. Comparison of steroid receptor expression in normal, dysplastic and neoplastic canine and feline mammary tissues. Research in Veterinary Science 79 (2005) 225-232
17. Millanta F., Calandrella M., Citi S., Della Santa D., and Poli A. Overexpression of HER-2 in feline invasive mammary carcinoma: an immunohistochemical survey and evaluation of its prognostic potential. Veterinary Pathology 42 (2005) 30-34
18. Misdorp W., Else R.W., Helmén E., and Lipscomb T.P. WHO International Histological Classification of Mammary Tumours of the Dog and Cat, Second Series vol. 7 (1999), The Armed Forced Institute of Pathology, American Registry of Pathology, Washington DC pp. 18-25
19. Nicosia R.F. What is the role of vascular endothelial growth factor-related molecules in tumour angiogenesis?. American Journal of Pathology 153 (1998) 11-16
20. Parton M., Dowsett M., Ashley S., Hills M., Lowe F., et al. High incidence of HER-positivity in inflammatory breast cancer. Breast 13 (2004) 97-103
21. Peña L., Pérez-Alenza M.D., Rodriguez Bertos A., and Nieto A. Canine inflammatory carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Research and Treatment 78 (2003) 141-148
22. Peña L., Silvàn G., Pérez-Alenza M.D., Nieto A., and Illera J.C. Steroid hormone profile of canine inflammatory carcinoma: a preliminary study. Journal of Steroid Biochemistry and Molecular Biology 84 (2003) 211-216
23. Pérez-Alenza M.D., Tabanera E., and Peña L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). Journal of the American Veterinary Medical Association 219 (2001) 1110-1114
24. Pérez-Alenza M.D., Jimènez A., Nieto A.I., and Peña L. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Breast Cancer Research 6 (2004) R300-R307
25. Qiu C., Lin D.D., Wang H.H., Qiao C.H., Wang J., et al. Quantification of VEGF-C expression in canine mammary tumours. Australian Veterinary Journal 86 (2008) 279-282
26. Restucci B., Papparella S., Maiolino P., and De Vico G. Expression of vascular endothelial growth factor in canine mammary tumours. Veterinary Pathology 39 (2002) 448-493
27. Robbins G., Shah J., Rosen P., Chu F., and Taylor J. Inflammatory carcinoma of the breast. Surgical Clinics of North America 54 (1974) 801-810
28. Sartin E.A., Barnes S., Kwapien R.P., and Wolfe L.G. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs. American Journal of Veterinary Research 53 (1992) 2196-2200
29. Scheidegger P., Weiglhofer W., Suarez S., Kaser-Hotz B., Steiner R., et al. Vascular endothelial growth factor (VEGF) and its receptors in tumour-bearing dogs. Biological Chemistry 380 (1999) 1449-1454
30. Shirakawa K., Shibuya M., Heike Y., Takashima S., Watanabe I., et al. Tumour-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer. International Journal of Cancer 99 (2002) 344-351
31. Susaneck S.J., Allen T.A., Hoopes J., Withrow S.J., and Macy D.W. Inflammatory mammary carcinoma in the dog. Journal of the American Animal Hospital Association 19 (1983) 971-976
32. Tavassoli F.A., and Devilee P. Tumours of the breast. In: Tavassoli F.A., and Devilee P. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Genital Organs (2003), IARC Press, Lyon 47-48
33. Van Der Auwera I., Van den Eynden G.G., Colpaert C.G., Van Laere S.J., Van Dam P., et al. Tumour lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research 11 (2005) 7637-7642
34. Wedam S.B., Low J.A., Yang S.X., Chow C.K., Choyke P., et al. Antiangiogenic and antitumour effects of Bevacizumab in patients with inflammatory and locally advanced breast cancer. Journal of Clinical Oncology 24 (2006) 769-777
35. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumour angiogenesis and metastasis: correlation in invasive breast carcinoma. New England Journal of Medicine 324 (1991) 1-8